Navigation Links
Codon Bias-Adjusted BL21 Derivatives for Protein Expression


High-level expression of difficult heterologous proteins

Carsten-Peter Carstens Anna Waesche
Stratagene

Stratagene has created variants of the Epicurian Coli BL21-Gold cells * called the BL21-CodonPlus -RIL series** of strains, which contain extra copies of the E. coli argU, ileY, and leuW tRNA genes. This modification allows for a high-level expression of proteins that are difficult to express in conventional E. coli hosts due to the codon bias of the gene of interest. The BL21-CodonPlus-RIL strains can eliminate the need to move the gene of interest into eukaryotic expression systems.

BL21-Gold(DE3) cells are the strain of choice for high-level production of heterologous proteins expressed from the T7-promoter. These strains have been engineered to contain an inducible T7-RNA polymerase. They are also EndA- to allow high-quality miniprep DNA preparation.1 BL21 competent cells are derivatives of E. coliB and lack the Lon protease and the ompT protease genes that may cause instability and degradation of the recombinant protein.

Table 1
Rarest Codons (from E. coli) Preferred by Selected Organisms

Codon frequencies are expressed as codons used per 1000 codons encountered. A complete compilation of codon usage of the sequences placed in the gene bank database can be found at http://www.dna.affrc.go.jp/~nakamura/codon.html Codon frequencies of more than 15 codons/1000 codons are shown in bold to help identify a codon bias that may cause problems for high-level expression in E. coli. The arginine codons AGG and AGA are recognized by the same tRNA (product of the argU gene) and should therefore be combined. However, regardless of the origin of the coding region of interest, each gene should be assessed individually. Even E. coli contains genes with poor codon usage for efficient translation.

AGG arginine

AGA arginine

CGA arginine

CUA leucine

AUA isoleucine

CCC proline

Escherichia coli

1.4

2.1

3.1

3.2

4.1

4.3

Homo sapiens

11.0

11.3

6.1

6.5

6.9

20.3

Drosophila melanogaster

4.7

5.7

7.6

7.2

8.3

18.6

Caenorhabditis elegans

3.8

15.6

11.5

7.9

9.8

4.3

Saccharomyces cerevisiae

9.3

21.3

3.0

13.4

17.8

6.8

Plasmodium falciparium

4.1

20.2

0.5

15.2

33.2

8.5

Clostridium pasteurianum

2.4

32.8

0.8

6.0

52.5

1.0

Pyrococcus horikoshii

30.3

20.4

1.0

18.0

44.9

10.1

Thermus aquaticus

13.7

1.4

1.4

3.2

2.0

43.0

Arabidopsis thaliana

10.9

18.4

6.0

9.8

12.6

5.2

Although strains of the BL21-Gold series are the most convenient and effective bacterial hosts for protein production presently available, expression of heterologous recombinant genes in E. coli is frequently limited when the codon usage in the recombinant gene differs from host cells (Table 1). Forced high-level expression of a gene, with codons that are rarely used by E. coli, results in depletion of the internal tRNA pools.2 As a consequence, translation of the recombinant RNA species is delayed, leading to its enhanced degradation. The result of rare codon usage is most frequently seen as ineffective to nondetectable production of the target protein and the formation of aborted translation products that have the appearance of proteolytic degradation. In addition, rare codons may also affect the quality of the produced proteins by inducing translation frameshifts, codon skipping, and frequent misincorporation of amino acids. Misincorporation rates of up to 40% have been reported at specific rare arginine codons.3

The deleterious effects of rarely used codons have been most thoroughly documented for the arginine codons AGA and AGG, which are the rarest codons in E. coli. However, codons for isoleucine (AUA), leucine (CUA), and proline (CCC) have also been demonstrated to affect protein production and quality in E. coli hosts. The expression of affected recombinant genes can be salvaged either by synonymous replacement of the rare codons with more frequently used codons using site-directed mutagenesis or by supplementing the host with extra copies of the cognate tRNA genes.

Now, Stratagene has generated BL21-CodonPlus-RIL chemically competent cells that carry extra copies of the argU, ileY, and leuW tRNA genes. The tRNAs encoded by these genes recognize the AGA/AGG, AUA, and CUA codons, respectively. To demonstrate their ability to facilitate the expression of heterologous recombinant genes that are only marginally expressed in conventional BL21 strains, BL21-CodonPlus(DE3)-RIL cells were transformed with vectors expressing genes fromhuman, yeast, and archaeal origins using the T7 RNA polymerase responsive promoter. IPTG-induced expression of all recombinant genes greatly increased in the BL21-CodonPlus(DE3)-RIL cells, compared to their expression in BL21-Gold(DE3) (Figure 1).

Fig.1

Expression of Difficult Proteins

To demonstrate the efficiency of BL21-CodonPlus-RIL cells to facilitate protein production in genes affected by poor codon usage, we compared the expression of a codon-adjusted form of the human cardiac troponin-T gene in conventional BL21-GoldDE3 cells (Figure 1,hcTnT-mut) with expression of the wild-type (hcTnT-wt) form in BL21-CodonPlus(DE3)-RIL cells. The expression of hcTnT in E. coli was previously shown to be solely restricted by the presence of two rare arginine codon pairs.4 This was demonstrated by synonymous replacement of the rare arginine codon pairs with frequently used arginine codons (hcTnT-mut), which results in efficient production of hcTnT-mut in E. coli. In Figure 1, BL21-CodonPlus(DE3)-RIL cells express hcTnT-wt at the same level observed for the codon-adjusted hcTnT-mut in conventional BL21-Gold(DE3) cells. Hence, using BL21-CodonPlus(DE3)-RIL strains are as efficient as employing the conventional and time-consuming method of synonymous replacement of rare codons to achieve high-level expression of codon-usage restricted recombinant genes.

Fig.2

The simultaneous expression of several rare tRNA genes in BL21-CodonPlus(DE3)-RIL not only provides a generic host for expression of recombinant genes affected by a range of rare codons but is also necessary for some recombinant genes to achieve a high level of expression. In Figure 2, using an archaeal gene as an example, efficient production of this recombinant gene in E. coli hosts requires the simultaneous presence of functional extra copies of both argU and ileY tRNA genes. Variants of the BL21-CodonPlus(DE3)-RIL strains lacking either the argU or ileY gene, while retaining the other tRNA genes, failed to produce the target gene at the same level as observed in the BL21-CodonPlus(DE3)-RIL strain. The functional expression argU and ileY genes in each of thevariant strains were confirmed using expression constructs, which are dependent only on either argU function (hcTnT) or ileY function (3xi) for efficient expression. The artificial construct 3xi is derived from a well-expressed recombinant gene by insertion of three AUA codons (ile) at the N-terminus.

The host cells did not suffer any obvious deleterious effects from the extra copies of tRNA genes. Growth rates and transformation efficiencies were comparable to the parental BL21-Gold cells. When comparing BL21-CodonPlus(DE3)-RIL cells with BL21-Gold(DE3) cells, production of recombinant genes like Jun-N-terminal kinase (JNK) or l-phosphatase, that are well expressed in conventional BL21 cells, were indistinguishable between the two strains (Figure 1).

Conclusions

Stratagenes new BL21-CodonPlus series of competent cells allows high-level expression of recombinant genes that are restricted in their expression in conventional E. coli due to codon usage bias. Many proteins can be expressed in BL21-CodonPlus-RIL cells instead of moving into a different expression system.

Acknowledgements

The authors thank Alan Greener, Connie Hansen, and Xiuyuan Hu.

REFERENCES
  1. Jerpseth, M., et al. (1998) Strategies 11: 3-4.

  2. Kane, J.F. (1995) Curr. Opin. Biotechnol. 6: 494-500.

  3. Forman, M.D., et al. (1998) Protein Sci. 7: 500-503.

  4. Hu, X., et al. (1996) Protein Expr. Purif. 7: 289-293.

* Patent pending
** Patents pending


'"/>

Source:


Page: All 1 2 3 4 5 6 7

Related biology technology :

1. High-Level Expression of Peanut Allergens Affected by Rare Codon Usage
2. New BL21-CodonPlus Cells Correct Codon Bias in GC-Rich Genomes
3. High-efficiency Derivatives of the BL21 Series for Protein Expression
4. A New C-Terminal GST Vector for Protein Production in S. pombe
5. New Mammalian Two-Hybrid System Detects Protein-Protein Interactions
6. Antibodies for Studying NMDA Receptor Protein Expression and Synapse-Specific Immunolabeling
7. Simple, Sensitive, and Rapid Detection of FLAG -Tagged Fusion Proteins
8. New Yeast Cloning System for Producing Proteins with Native Amino Acid Sequences
9. Optimized Imaging of Protein Gels Stained with Coomassie Brilliant Blue Dye
10. High-Level Protein Expression, One-Column Purification, and FLAG Epitope Tagging in E. coli
11. Transfection of Green Fluorescent Protein into Human Adrenalcarcinoma Cells
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Codon Bias Adjusted Derivatives for Protein Expression

(Date:4/23/2015)... 23, 2015 Proove Biosciences ... Medicine, is excited to announce the launch of ... This profile assesses 62 genetic variations to predict ... for commonly prescribed non-opioid pain medications, namely ibuprofen ... alprazolam (brand name Xanax) and acetaminophen (brand name ...
(Date:4/23/2015)... , April 23, 2015 /PRNewswire/ - Crystal Research Associates, ... Informational Overview ® (EIO) on Aeterna Zentaris Inc. ... is available on Crystal Research Associates, website at ... Zentaris, website at www.aezsinc.com . Aeterna ... specialty biopharmaceutical company in oncology, endocrinology, and women,s health. ...
(Date:4/22/2015)... -- The Heinz Family Foundation today announced the winners ... will present unrestricted cash awards totaling $1.25 million ... determination in finding solutions to critical issues both ... include a prolific cartoonist whose quirky characters depict ... two former Marines who are re-engaging veterans in ...
(Date:4/22/2015)... , April 22, 2015   MPIRICA ... today announced $1.6M in Series A financing from ... The funding helps accelerate consumer and employer awareness ... covering surgeries at over 4,800 U.S. hospitals. ... you are probably very concerned about choosing the ...
Breaking Biology Technology:Proove Biosciences Launches World’s First Test to Predict Responders to Commonly Prescribed Non-Opioid Pain Medications 2Proove Biosciences Launches World’s First Test to Predict Responders to Commonly Prescribed Non-Opioid Pain Medications 3Crystal Research Associates, LLC Issues Executive Informational Overview (EIO) on Aeterna Zentaris Inc. 2Crystal Research Associates, LLC Issues Executive Informational Overview (EIO) on Aeterna Zentaris Inc. 3From a Scientist Who Develops Human Microlivers to a New Yorker Cartoonist Who Masterfully Depicts the Humor and Heartbreak of Everyday Life: The 20th Heinz Awards Honors Six Changemakers 2From a Scientist Who Develops Human Microlivers to a New Yorker Cartoonist Who Masterfully Depicts the Humor and Heartbreak of Everyday Life: The 20th Heinz Awards Honors Six Changemakers 3From a Scientist Who Develops Human Microlivers to a New Yorker Cartoonist Who Masterfully Depicts the Humor and Heartbreak of Everyday Life: The 20th Heinz Awards Honors Six Changemakers 4From a Scientist Who Develops Human Microlivers to a New Yorker Cartoonist Who Masterfully Depicts the Humor and Heartbreak of Everyday Life: The 20th Heinz Awards Honors Six Changemakers 5From a Scientist Who Develops Human Microlivers to a New Yorker Cartoonist Who Masterfully Depicts the Humor and Heartbreak of Everyday Life: The 20th Heinz Awards Honors Six Changemakers 6MPIRICA Health Inc. Secures $1.6M to Promote FICO-Like Quality Scores for Surgeries 2
... Agreement Enables Spherix to Pursue All Pharmaceutical and Health-Oriented ... June 23 Spherix Incorporated (Nasdaq: SPEX ... a provider of technical and regulatory consulting services to ... it has terminated the 1996 license agreement pursuant to ...
... SAO PAULO, June 23 What does sugarcane have ... successful,30-year experience with sugarcane as a feedstock for ethanol. In ... replace a fossil fuel with,renewable energy has saved some 600 ... years for six billion trees to achieve the same,results. , ...
... , Continuing Supplies Will Be Used For NDA and ... Type 2 Diabetes , , BETHESDA, Md., June ... an innovator in biotechnology for diabetes therapy, and a ... supplement, biotechnology and pharmaceutical companies, today announced that it ...
Cached Biology Technology:Spherix Announces Termination of Arla License Agreement 2Spherix Announces Termination of Arla License Agreement 3Spherix Announces Termination of Arla License Agreement 4Sugarcane as a Key Element Against Global Warming to be Highlighted at Green Week in Brussels 2Sugarcane as a Key Element Against Global Warming to be Highlighted at Green Week in Brussels 3Sugarcane as a Key Element Against Global Warming to be Highlighted at Green Week in Brussels 4Spherix Announces Full-Scale Production of Pharmaceutical Tagatose 2Spherix Announces Full-Scale Production of Pharmaceutical Tagatose 3Spherix Announces Full-Scale Production of Pharmaceutical Tagatose 4
(Date:3/20/2015)... , Mar. 19, 2015 Research and Markets ... "Hand Geometry - Global Strategic Business Report" report ... markets for Hand Geometry in US$ Thousands. The report provides ... , Japan , Europe ... , and Rest of World. Annual estimates ...
(Date:3/19/2015)... , March 19, 2015  NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market, announces its ... a news clip that aired this week on ... . In a segment "The Next Great Thing", ... ,a new way to pay, and ,a really big breakthrough ...
(Date:3/17/2015)... March 17, 2015 Emotient, the leader ... today announced general availability of Emotient Analytics ... the analysis of facial expressions. The system analyzes ... content, products and services. It delivers audience response ... sentiment - as derived from facial evidence of ...
Breaking Biology News(10 mins):Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 2Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 4NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 2NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 3New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 2New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 3New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 4
... NT APRIL 2010 High in the Mackenzie Mountains, ... being revealed as warming temperatures melt patches of ice that ... Tom Andrews, an archaeologist with the Prince of Wales Northern ... Polar Year Ice Patch Study, is amazed at the implements ...
... April 26, 2010 Energy in, energy out, it,s the ... more than two thirds of Americans classified as overweight or ... Journal of Nutrition Education and Behavior examines how ... loss programs. Researchers at the University of Kentucky and ...
... 26 BIO-key International, Inc. (OTC Bulletin Board: BKYI), a leader ... (OK) Sheriff,s Office successful deployment of an FBI-compliant advanced authentication solution for ... authentication. , , , ... http://www.newscom.com/cgi-bin/prnh/20050509/BIOKEYLOGO ) , , , ...
Cached Biology News:Ancient artifacts reveals as northern ice patches melt 2What's motivation got to do with weight loss? 2BIO-key(R) Delivers FBI-Compliant 2 Factor Authentication Solution for First Responders 2BIO-key(R) Delivers FBI-Compliant 2 Factor Authentication Solution for First Responders 3BIO-key(R) Delivers FBI-Compliant 2 Factor Authentication Solution for First Responders 4
... GRADE ,5-Bromo-4-chloro-3-indoxyl-beta-D-galactopyranoside C 14 H ... 6 ,M.W.= 408.63 ,Assay: Greater ... in DMF) ,Biological Activity: Blue color ... Analysis: Agrees with theoretical values ,Thin ...
BD IMagnet 1 each...
... and M.W. Turner (1997). • This ... used in the production of high-quality ... immunoassays, the standardisation of antibodies and ... amplification systems, enzyme immunoassays for detecting ...
MitoScreen (JC-1) Kit , 100 tests Consult technical datasheet for details....
Biology Products: